If Pfizer were a country, it would have the 66th largest GDP in the world

10th February 2022 / NewsBits, United Kingdom

Global Justice Now, a social justice group campaigning for equitable access to Covid-19 vaccines, highlights that:

  • Pfizer’s annual revenue has doubled to $81 billion, more than the GDP of the majority of countries. If Pfizer were a country, it would have the 66th largest GDP in the world, ahead of countries like Ethiopia, Kenya, Ghana, Guatemala, Oman, and Luxembourg. (1)
  • Pfizer’s bumper revenues are driven largely by their vaccine, which was first developed by smaller German company BioNTech with €100m in debt financing from the publicly-owned European Investment Bank and a €375m grant from the German government. Pfizer also received a $1.9 billion early order from the US government to de-risk R&D. (3)
  • Pfizer has charged Britain’s National Health Service (NHS) an estimated  £2.82 billion above production cost for the 189 million doses of Covid-19 vaccines the UK has bought.
  • Pfizer says that a non-profit dose of their vaccine costs just $6.75, or £4.98, to produce, but it has reportedly charged the NHS £18 a dose for the first 100 million purchased and £22 a dose for the next 89 million, totalling £3.76 billion.(3, 4) This amounts to an “eye-watering” 299% mark-up (4). Experts estimate the true cost price to be even lower.


Source: Global Justice Now



At a time when reporting the truth is critical, your support is essential in protecting it.
Find out how

Related Articles:

The European Financial Review

European financial review Logo

The European Financial Review is the leading financial intelligence magazine read widely by financial experts and the wider business community.